Corrigendum: Efficacy and Safety of CAR-T Cell Products Axicabtagene Ciloleucel, Tisagenlecleucel, and Lisocabtagene Maraleucel for the Treatment of Hematologic Malignancies: A Systematic Review and Meta-Analysis

Bibliographic Details
Published in:Frontiers in Oncology
Main Authors: Jun Meng, XiaoQin Wu, Zhen Sun, RenDe Xun, MengSi Liu, Rui Hu, JianChao Huang
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-10-01
Subjects:
chimeric antigen receptor T-cell product
CAR-T cell therapy
immunotherapy
lymphoma
leukemia
hematologic malignancy
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.768128/full
Description
ISSN:2234-943X

Similar Items